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Morbidity of transrectal ultrasound guided prostate biopsy*
Morbidade da biópsia da próstata transretal guiada por ultrassonografia
Raphael Sandes Solha1, Sérgio Ajzen2, Harley De Nicola3, David Carlos Shigueoka4,
Hugo Alexandre Sócrates de Castro5
Objective: To evaluate the incidence of postprocedural complications in patients submitted to transrectal ultrasound-
guided prostate biopsy at the Unit of Intervention, Department of Imaging Diagnosis of Escola Paulista de Medicina –
Universidade Federal de São Paulo. Materials and Methods: Telephone interviews were conducted with 132 patients
who had undergone transrectal ultrasound-guided prostate biopsy in the period from April 2011 to June 2011, according
to the institution’s protocol. Results: Post-biopsy complications were categorized into two groups – minor and major
complications, according to their need for further clinical evaluation. Complications were reported by 59 patients
(61.8%), most of them (86.4%) with mild and self-limited symptoms, classified as minor complications. Eight patients
(8.2%) had major complications, one of which required in-hospital treatment. Urinary retention was the major and
most common complication. Conclusion: The present study has demonstrated a low prevalence of major complications
after transrectal prostate biopsy.
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Objetivo: Avaliar a incidência de complicações pós-procedimento nos pacientes submetidos a biópsia prostática
transretal guiada por ultrassom no setor de intervenção do Departamento de Diagnóstico por Imagem da Escola
Paulista de Medicina – Universidade Federal de São Paulo. Materiais e Métodos: Foram avaliados, via contato
telefônico, 132 pacientes submetidos a biópsia de próstata transretal guiada por ultrassom no período de abril/2011
a junho/2011, seguindo o protocolo padrão do nosso setor. Resultados: As complicações pós-biópsia foram catego-
rizadas em maiores e menores de acordo com a necessidade de avaliação médica adicional. Cinquenta e nove
pacientes (61,8%) apresentaram complicações, e desses, grande parte (86,4%) apresentou sintomas leves e autoli-
mitados, considerados menores. Oito pacientes (8,2%) apresentaram complicações maiores, sendo que apenas um
deles necessitou de tratamento sob regime de internação hospitalar. A retenção urinária foi a complicação maior mais
incidente no nosso estudo. Conclusão: Corroborando outros estudos da literatura, nosso trabalho demonstrou baixa
prevalência de complicações maiores após a biópsia prostática transretal.
Unitermos: Próstata; Biópsia; Morbidade; Ultrassonografia; Complicações.
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ORIGINAL ARTICLE
In spite of developments in different
imaging diagnosis methods applied to evalu-
ate pelvic diseases, the confirmation of pros-
tate cancer diagnosis is still achieved by
means of histological evaluation of speci-
mens obtained by transrectal biopsy(5,6), a
procedure that is generally safe and well
tolerated by patients. However, some stud-
ies have reported complication rates of up
to 73%, as immediate and spontaneous reso-
lution events are included(7). In the Unit of
Nonvascular Intervention, Department of
Imaging Diagnosis of Escola Paulista de
Medicina – Universidade Federal de São
Paulo (DDI/EPM-Unifesp), a reference cen-
ter for a great part of the population from
the Southern region of the city of São Paulo,
approximately 80 prostate biopsies are per-
formed every month, comprising 36% of
cer is the most common type of cancer
among men, and according to Instituto
Nacional de Câncer, 52,350 new cases
were estimated in 2010(2). In most of cases,
the disease affects individuals above the
age of 50, and it is a heterogeneous entity
whose features vary from asymptomatic
presentations to fast-growing disease(3). Its
mortality rate is relatively low, especially
cases with early diagnosis. Such mortality
rate has decreased over the recent years,
with five-year survival rates reaching 99%
because of screening programs, early detec-
tion and changes in life style(4).
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INTRODUCTION
Prostate cancer is the most common
neoplasia among men in America, and the
second cause of cancer death in this popu-
lation group(1). Also in Brazil, prostate can-
72
Solha RS et al. Transrectal US-guided prostate biopsy
Radiol Bras. 2013 Mar/Abr;46(2):71–74
the total number of procedures performed
in that unit. Normally, complications fol-
lowing transrectal biopsy of the prostate are
mild and self-limited, including hematuria,
hematospermia or transient rectal bleeding.
Sometimes, more severe complications
such as urinary retention, infectious events
and important rectal bleeding may occur,
requiring further treatment(8).
The present study was aimed at evalu-
ating the incidence of post-procedural com-
plications in patients submitted to trans-
rectal US-guided biopsy of the prostate in
the Unit of Intervention of DDI/EPM-
Unifesp.
MATERIALS AND METHODS
In the period from April to July 2011,
132 patients with clinical and laboratory
suspicion of prostate cancer were referred
to the authors’ institution referred to the
authors´ sector for clinical or laboratorial
prostate cancer suspect were sequentially
submitted to transrectal prostate biopsies
and were sequentially evaluated. All the
patients were submitted to the same
transrectal ultrasound guided prostate bi-
opsy protocol utilized in the unit, after pro-
phylactic antibiotic therapy with ciproflo-
xacin. After positioning the patient in left
lateral decubitus with flexed thighs, an
endocavitary transducer coupled with a
specific biopsy probe was inserted, and the
transrectal sonographic evaluation of the
prostate was performed. Then, periprostatic
block anesthesia was performed with 5 ml
of 2% lidocaine diluted in 5 ml of saline
solution, utilizing an 18-gauge needle.
After anesthesia, the biopsy was per-
formed with collection 12 representative
gland specimens utilizing an 18-gauge
needle, following the sextant pattern rec-
ommended by Colégio Brasileiro de Radio-
logia e Diagnóstico por Imagem and by
Sociedade Brasileira de Urologia. Upon
sonographic findings (focal lesions in the
peripheral zone) or upon medical request
(palpation findings or saturation re-biopsy
– 18 specimens) additional specimens were
collected. The patients were discharged
after first urination with no evidence of
significant hematuria and after being prop-
erly instructed on a possible onset of late
complications.
By means of telephone interviews,
questionnaires were filled out on febrile or
hemorrhagic adverse events occurring
within 14 days after prostate biopsy. In such
a questionnaire, the events were reported
as hematuria, hematospermia or hemato-
chezia, measured febrile event, chills, dys-
uria or urinary retention and respective pro-
gression and/or treatments.
Among the 132 patients who underwent
biopsy in the period, 29 were excluded be-
cause of contact impossibilities after three
attempts at different days and times, four
for having undergone the procedure during
hospital stay, and one for death by unrelated
cause (cardiovascular event) and one for
having been submitted to the procedure
under a different protocol from that estab-
lished by the institution (under sedation).
For evaluation purposes, the complica-
tions were divided into two groups: major
complications and minor complications.
Major complications were those which led
the patients to seek emergency medical as-
sistance after being discharged. All the other
complications were considered as being
minor, self-limited and inherent to the risks
associated with an invasive procedure.
RESULTS
The 97 selected patients were aged be-
tween 43 and 83, with a mean age of 66.2
years. Among the patients, 38 (39.2%) did
not present with any adverse event after
prostate biopsy. On the other hand, 51 pa-
tients (52.6%) reported at least one minor
complication, most of them (76.5%) with
only an isolated symptom or sign. In this
group, macroscopic hematuria was the most
prevalent complication, reported by 39 pa-
tients. The hematuria lasted from one to ten
days (men 3.2 days), with 62.5% of such
cases presenting spontaneous resolution
within the first three days and 5% of the
cases persisting for more than one week.
Hematospermia was the second most
frequent reported sign, present in 23.7% of
the patients after biopsy. Most of such pa-
tients (82.6%) presented spontaneous re-
mission of the hematospermia, while the
symptom persisted in four patients at the
time of the telephone interview. None of
such patients reported the need to seek
medical assistance for such a reason.
Two patients (2%) reported hemato-
chezia, both cases with spontaneous reso-
lution, one within one day and the other
after 7 days.
As regards major complications, eight
patients (8.2%) required emergency medi-
cal evaluation. Among them, seven
(87.5%) sought medical assistance for uri-
nary retention, requiring urinary catheter
insertion, with three of the patients requir-
ing associated home antibiotic therapy.
Three patients (3.1%) reported fever, in
two cases associated with dysuria, requir-
ing urinary catheter insertion and home
antibiotic therapy. One of the patients with
measured fever reported spontaneous reso-
lution, with no need of further specific
treatment.
Only one patient reported persistent
hematuria in association with dysuria, lead-
ing him to seek medical assistance at the
hospital where he was admitted for treat-
ment with antibiotics. However such pa-
tient reported concomitant respiratory
symptoms, which has impaired the direct
correlation between such an event and the
procedure itself. Other five patients also
reported dysuria, although with spontane-
ous resolution, without the need for addi-
tional medical evaluation.
Chills were the symptoms with the low-
est prevalence, being reported by only one
patient, in association with fever and uri-
nary retention.
Table 1 shows the complications re-
ported by the patients.
Table 1 Late complications after transrectal
ultrasound guided prostate biopsy.
Signs and
symptoms
Hematuria
Hematospermia
Urinary retention
Dysuria
Fever
Hematochezia
Chills
Present
39 (40.2)
23 (23.7)
7 (7.2)
6 (6.2)
3 (3.1)
2 (2.1)
1 (1.0)
Absent
58 (59.8)
74 (76.3)
90 (92.8)
91 (93.8)
94 (96.9)
95 (97.9)
96 (99.0)
Number of patients (%)
DISCUSSION
Early detection of prostate cancer is
critical for a favorable prognosis, with con-
sequential reduction in morbidity in pa-
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tients presenting with the disease. With the
increase in prostate cancer screening, both
in private and public services, the number
of transrectal ultrasound guided biopsies
tends to increase, so the knowledge on the
inherent complications of the method(9)
becomes indispensable for both the
interventional radiologist and the request-
ing physician.
In the present study, 59 patients (60.8%)
reported at least one late complication af-
ter prostate biopsy. Some other studies,
such as that developed by Miller et al., have
found less significant complication rates,
achieving 9.6%, however the authors have
not taken minor and self-limited complica-
tions into consideration(10). In the absence
of an effective standardization of the post-
procedural complications, the authors of
the present study have opted for consider-
ing the need for further medical evaluation
as a definition of major complication, be-
cause of its greater socioeconomic impact.
Thus a prevalence of 8.2% for major com-
plications and 52.6% for minor complica-
tions were observed. Such rates are equiva-
lent to those reported by other studies in the
international literature, such as the one
developed by Rodriguez et al., who have
found similar prevalence (63.6%) of post-
procedural complications, also with hema-
turia being the main symptom found by
those authors (47.1%)(11).
Post-biopsy macroscopic hematuria is
generally a self-limited and very common
event, reported by 40.2% of the patients
included in the present study. In a study
undertaken in Rotterdam, Holland, Riet-
bergen et al. have evaluated 1,687 patients
submitted to prostate biopsies, and found
a similar prevalence (45.3%)(12). For being
a very common symptom, some authors,
such as Raaijmakers et al., have considered
as being complications only those cases
where hematuria persisted for more than
three days(13), obtaining a prevalence of
22.6%. In the present study, only eight
(8.2%) patients met that criterion. Hema-
tospermia was the second most commonly
found sign, present in 23.7% of the patients
included in the present study, with none
being considered as a major complication.
In the literature, a great variation – from
9.1% to 78.3% – is observed with respect
to the prevalence of hematospermia follow-
ing prostate biopsy(11,14). The highest preva-
lence (78.3%) was reported by Peyromaure
et al., who have considered only the rela-
tionship between hematospermia and pa-
tients who reported sexual activity in the
evaluated period(14). As related to the total
number of patients, a prevalence of 54.9%
was found, a rate that is much higher than
the prevalence observed in the present
study.
Generally associated with urinary tract
infections (UTI), dysuria, fever or chills
were reported by ten patients included in
the present study, but, among those pa-
tients, only three (3.1%) were characterized
as major events. Urinary tract infection is
considered as being the second most fre-
quent complication of prostate biopsy, only
after hemorrhagic complications. In spite
of being a simple event, UTI occurs with a
certain frequency after prostate biopsies,
and febrile UTIs are not uncommon after
the procedure(15,16). Sepsis is one of the
most severe complications, albeit rare, be-
ing found in less than 2% of cases(12). In the
authors’ institution, since 2007, only one
patient required admission to intensive care
unit because of sepias following prostate
biopsy, and was released after 14 days of
treatment. Studies have evidenced the pres-
ence of asymptomatic bacteriuria and tran-
sient bacteremia in 16% to 100% of cases
after the procedure(17,18), hence the current
consensus on the importance of prophylac-
tic antibiotic therapy in the preparation of
the patient before performance of the bi-
opsy, with the purpose of maintaining the
low rates of complications caused by such
procedure(19,20). However, many studies
have pointed out the lack of a standard al-
gorithm to be followed in such prepara-
tion(21).
In spite of the fact that in the present
study the rate of major complications
(8.2%) was comparable to those in most
services performing such studies utilizing
similar criteria(22), a high incidence of uri-
nary retention was observed as compared
with similar studies in the literature (Table
2). Among the risk factors for urinary re-
tention in the general population, several
such factors are present in the patients sub-
mitted to biopsy: previous history of ob-
struction caused by increased prostate vol-
ume or by potential obstruction due to pres-
Table 2 Literature review on urinary retention at
transrectal ultrasound guided prostate biopsy.
Reference
Jeon et al.(7)
Rodríguez et al.(11)
Rietbergen et al.(12)
Raaijmakers et at.(13)
Djavan et al.(15)
Lee et al.(22)
Solha et al. (present study)
Urinary
retention
1.1%
1.6%
0.4%
0.4%
2.6%
1.7%
7.2%
ence of hematuria, concomitant infection
– particularly prostatitis –, and use of drugs
with anticholinergic properties (tricyclic
antidepressants, alpha adrenergic blockers
and non-steroidal anti-inflammatory drugs).
Some postoperative conditions are similar
to those observed after biopsy, for example
occurrence of pain or anesthetic proce-
dure(23). In the authors’ experience, the pa-
tients discharge only after the first clear
urination should suffice to prevent such
complication. Besides highlighting such
patients discharge criterion, such finding
demonstrates the need for further studies to
investigate its possible causes, indicating
new criteria or additional measures aimed
at further reducing the incidence of such
complications.
CONCLUSION
The authors conclude that, in spite of
the rate of urinary retention reported by
patients in the present study being higher
than average in the cited studies, the preva-
lence of major and minor complications in
their institution is comparable to that in
other services dedicated to this procedures,
corroborating their safety and the low in-
cidence of major late complications.
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